1 Min Read
March 12 (Reuters) - Ctd Holdings Inc:
* CTD HOLDINGS ANNOUNCES FDA AUTHORIZATION TO PROCEED WITH SINGLE PATIENT IND FOR USE OF TRAPPSOL(R) CYCLO(TM) TO TREAT ALZHEIMER’S DISEASE Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.